Policy | July 14, 2024
7th India-Japan medical product regulatory symposium held at New Delhi
Enhanced collaboration under the Memorandum of Cooperation (MoC) between India and Japan in medical product regulations
Enhanced collaboration under the Memorandum of Cooperation (MoC) between India and Japan in medical product regulations
Acquisition to expand Lilly's immunology pipeline with oral integrin therapies
The My Green Lab Certification is the gold standard for laboratory sustainability practices worldwide
Dr. Roopal Thakkar joined Abbott/AbbVie in 2003 as part of the Physician Development Program
Olverembatinib, a novel drug developed by Ascentage Pharma with support from the National Major New Drug Development program
The academy has secured partnerships with 15 esteemed hospitals
CureVac receives €400 million upfront and up to an additional €1.05 billion in development, regulatory and sales milestone payments as well as tiered royalties; all previous financial considerations from the prior collaboration agreement replaced
Ibara will drive AI-powered clinical research innovation
Ascentage Pharma announces confidential submission of draft registration statement for proposed IPO
Approval based on CAPItello-291 results which showed this combination reduced the risk of disease progression or death by 50% vs. Faslodex alone in a biomarker-altered population
Subscribe To Our Newsletter & Stay Updated
